(Feb 1): Singapore Medical Group and South Korea's CHA Healthcare Co have together bought a majority stake in Australia's fourth-largest fertility clinic operator, City Fertility Centre.

Neither party disclosed a price in statements issued late on Wednesday and early on Thursday.

Falling fertility rates across the region is spurring growth and deal-making in the in-vitro fertilisation (IVF) industry. "A growing number of delayed pregnancies among women (and) rising awareness pertaining to infertility ... are driving aggressive growth in the global IVF market," Singapore Medical Group Executive Director Beng Teck Liang said in the statement sent to the Singapore Securities Exchange.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories


    Stay updated with Singapore corporate news stories for FREE

    Follow our Telegram | Facebook